Seth Birnbaum
Analyst · Canaccord. Your line is open.
Sure. So, recall. Hi Michael, thank you again, thanks for joining us and I appreciate the kind comments. You recalled we don't have much of any connective tissue with car shopping, 98%, 97% vast majority of the consumer demand is renewals is folk shopping to look for discounts, coverage, perhaps they've had a claim. So again, there's very little to no connective tissue for us with car shopping. In addition, switching obviously may be a net positive for us, but we're not reliant on it in our market. If a consumer comes through and finds out, Hey, I'm with a great provider and renewing with them is a good match, that's perfectly fine by us, there's a number of carriers and agents who in fact I think the vast majority I believe, run some kind of retention campaign with us to retain consumers, which we support for both the consumer and the provider. So again, we don't expect much impact at all from – any changes to car shopping or switching behavior, which is part of what's resilience about our marketplace model for insurance, right. So that's a benefit for us as well as our partners and customers. On the healthcare side, I mean it's just going to be continued investment in engineering and data head count, recall that, as we scale these verticals they're able to leverage the investments we've made in data, platforms, product systems. So it's a very high leverage activity scaling in the health vertical from an operating leverage perspective, but we will continue and do continue to add head count and talent, particularly tech talent to the healthcare vertical team.